Skip to main content

Table 1 Number of enrollees in each age groupa

From: Cost of inappropriate antimicrobial use for upper respiratory infection in Japan

Age group (years)

2013

2014

2015

2016

0–4

300,045 (5·73)

349,827 (6·71)

364,043 (7·27)

378,095 (7·62)

5–9

186,265 (3·47)

199,763 (3·76)

190,513 (3·58)

183,465 (3·46)

10–14

178,937 (3·09)

195,988 (3·43)

185,914 (3·31)

178,224 (3·23)

15–19

181,308 (3·0)

232,657 (3·87)

229,207 (3·79)

229,102 (3·79)

20–24

206,669 (3·33)

301,604 (4·86)

310,845 (5·10)

319,438 (5·19)

25–29

234,889 (3·42)

301,904 (4·52)

301,886 (4·62)

303,908 (4·75)

30–34

254,486 (3·34)

304,273 (4·08)

298,905 (4·04)

297,681 (4·10)

35–39

279,942 (3·09)

319,855 (3·69)

309,508 (3·68)

302,943 (3·73)

40–44

266,656 (2·76)

299,446 (3·06)

288,814 (2·93)

281,933 (2·90)

45–49

219,357 (2·61)

242,943 (2·82)

233,439 (2·66)

227,467 (2·45)

50–54

174,821 (2·26)

198,847 (2·55)

190,321 (2·37)

184,999 (2·34)

55–59

129,055 (1·67)

172,490 (2·25)

164,890 (2·17)

159,649 (2·12)

60–64

107,417 (1·11)

146,718 (1·63)

142,367 (1·66)

138,287 (1·70)

Total

2,719,847 (2·85)

3,266,315 (3·47)

3,210,652 (3·44)

3,185,191 (3·45)

  1. aValues in parentheses represent the proportion of enrollees of total number of Japanese populations in each age group